Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2026)
Tango Therapeutics (TNGX) recorded quarterly Other Working Capital Changes of -$781000.0 in Q1 2026, down 123.14% quarter-over-quarter from -$350000.0 in Q4 2025, and down 20.34% on a YoY basis from -$980404.3 in Q1 2025.
Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Tango Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$781000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 20.34% year-over-year to -$781000.0; the TTM figure through Mar 2026 stood at $1.6 million (up 105.36% YoY), while the FY2025 annual figure was $1.8 million, up 105.88% from the prior year.
- Other Working Capital Changes was -$781000.0 for Q1 2026 at Tango Therapeutics, down from -$350000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $10.7 million in Q3 2025 to a low of -$28.7 million in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$1.7 million across 5 years, with a median of -$463000.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 3615.85% in 2022, then tumbled 4799.32% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $401000.0 in 2022, then plunged by 246.13% to -$586000.0 in 2023, then sank by 4799.32% to -$28.7 million in 2024, then surged by 98.78% to -$350000.0 in 2025, then tumbled by 123.14% to -$781000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$781000.0 (Q1 2026), -$350000.0 (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tango Therapeutics | 4.05 Bn | 3.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -781,000.00 |
| Mar 31, 2026 | -781,000.00 |
| Dec 31, 2025 | -350,000.00 |
| Dec 31, 2025 | -350,000.00 |
| Sep 30, 2025 | 10.69 Mn |
| Sep 30, 2025 | 10.69 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -7.92 Mn |
| Mar 31, 2025 | -649,000.00 |
| Mar 31, 2025 | -649,000.00 |
| Dec 31, 2024 | -28.71 Mn |
| Dec 31, 2024 | -28.71 Mn |
| Sep 30, 2024 | -463,000.00 |
| Sep 30, 2024 | -463,000.00 |
| Jun 30, 2024 | -608,000.00 |
| Jun 30, 2024 | -608,000.00 |
| Mar 31, 2024 | -188,000.00 |
| Mar 31, 2024 | -188,000.00 |
| Dec 31, 2023 | -586,000.00 |
| Dec 31, 2023 | -586,000.00 |